Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1122-2019

Drug recall · April 17, 2019

Telmisartan and Amlodipine Tablets 80 mg/5 mg recall

Why: Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30

Lots / codes

Lots: 201916 Exp. 08/2019; 20092 Exp. 08/2019

Quantity
397 bottles
Company
AVKARE Inc., Pulaski, TN
Distribution
AZ, CO
Initiated
April 3, 2019 · Voluntary: Firm initiated
Classified
April 11, 2019
Reported
April 17, 2019
Ended
May 7, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Amlodipine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.